Views & Analysis High-value, high-cost drugs: how to pay for them Experts call for urgent development of new drug funding mechanisms.
Views & Analysis Tunnah’s musings: Hope over hype for pharma in patient centr... Three areas where the pharma industry will advance in 2017 as it looks beyond the hype.
Events Partner Content Making Pharmaceuticals 25 & 26 April 2017 Exhibition & Conference for Pharma Professionals
Views & Analysis Unified systems mean faster clinical trials Inefficient processes, legacy infrastructure and a silo culture are slowing access to critical trial data.
Views & Analysis How can pharma help NHS improve mental health services? Sustainability and Transformation Plans present an opportunity for pharma to support research into mental health conditions.
Views & Analysis From treatment to technology: a personal journey William King, founder and executive chairman of Zephyr Health, on using predictive insights for business transformation.
Patients Making direct-to-patient work, with Matt Wadyka Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
